Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hemorrhage × N(4)-oleylcytosine arabinoside × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Venous Thromboembolism 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Hemorrhage 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Tranexamic Acid 2 carbetocin 1 Surveys and Questionnaires 1 Solutions 1 Sodium Chloride 1 Saline Solution 1 N(4)-oleylcytosine arabinoside 1 Methylergonovine 1 Injections, Intravenous 1 Ergonovine 1 Enoxaparin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05198960 2025-02-04

AVAJAK

University Hospital, Brest

Phase 3 Recruiting

Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡